| Literature DB >> 22538855 |
Renee J Robb1, Katie E Lineburg, Rachel D Kuns, Yana A Wilson, Neil C Raffelt, Stuart D Olver, Antiopi Varelias, Kylie A Alexander, Bianca E Teal, Tim Sparwasser, Gunter J Hammerling, Kate A Markey, Motoko Koyama, Andrew D Clouston, Christian R Engwerda, Geoffrey R Hill, Kelli P A MacDonald.
Abstract
FoxP3(+) confers suppressive properties and is confined to regulatory T cells (T(reg)) that potently inhibit autoreactive immune responses. In the transplant setting, natural CD4(+) T(reg) are critical in controlling alloreactivity and the establishment of tolerance. We now identify an important CD8(+) population of FoxP3(+) T(reg) that convert from CD8(+) conventional donor T cells after allogeneic but not syngeneic bone marrow transplantation. These CD8(+) T(reg) undergo conversion in the mesenteric lymph nodes under the influence of recipient dendritic cells and TGF-β. Importantly, this population is as important for protection from GVHD as the well-studied natural CD4(+)FoxP3(+) population and is more potent in exerting class I-restricted and antigen-specific suppression in vitro and in vivo. Critically, CD8(+)FoxP3(+) T(reg) are exquisitely sensitive to inhibition by cyclosporine but can be massively and specifically expanded in vivo to prevent GVHD by coadministering rapamycin and IL-2 antibody complexes. CD8(+)FoxP3(+) T(reg) thus represent a new regulatory population with considerable potential to preferentially subvert MHC class I-restricted T-cell responses after bone marrow transplantation.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22538855 DOI: 10.1182/blood-2011-12-396119
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113